drugset / Trial / NCT01948362

Sulforadex in Healthy Volunteers SAD

NCT01948362

Phase 1 Completed 29 enrolled Evgen Pharma
RandomizedSingle-groupQuadruple-blindTreatment

Summary

To determine the safety and tolerability of single escalating doses of Sulforadex® in healthy male volunteers.

Timeline

Start
2012-11
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sulforaphane Small molecule

Indications